EASL is excited to bring you a packed schedule of webinars this October and November, designed to keep you at the forefront of hepatology. From cutting-edge research to clinical insights, our expert-led sessions cover key topics such as endoscopy, hepatic decompensation, hepatocellular adenoma, and metabolic-associated liver diseases.
Make sure to mark your calendars and join us for these events.
Whether you're a clinician, researcher, or student, there's something for everyone!
EASL Journal Club ¦ Tuesday, 22 October 2024 at 18:00 CET
Join the authors and other experts as they discuss this European multicentre study investigating the prognostic role of HVPG in metabolic dysfunction-associated steatotic liver disease (MASLD)-related compensated advanced chronic liver disease (cACLD), focusing on portal hypertension as a driver of hepatic decompensation.
EASL Molecular Tumour Board ¦ Tuesday, 29 October at 18:00 CET
In this new EASL Molecular Tumour Board (EASL-MTB) the multidisciplinary panel of experts will discuss a clinical case of hepatocellular adenoma (HCA). Watch on demand to hear the discussion and get more insight into precision oncology based on molecular data in primary liver malignancies.
EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease? ¦ Wednesday, 30 October 2024 at 18:00 CET
In this second edition of the EASL DeepDive, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke will provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they will review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.
This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim.has had no input into the content of this EASL DeepDive.
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency ¦ Wednesday, 06 November at 18:00 CET
Join Verena Keitel, Alice Turner, Pavel Strnad, and Nicola Brunetti-Pieri in this EASL DeepDive as they discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.
This EASL DeepDive webinar is supported by Takeda.Takeda has had no input into the content of this EASL DeepDive.
EASL-ESGE Course on Endoscopy ¦ Module 5 is out!
Explore all 5 CME-accredited modules—covering general endoscopy, portal hypertension, and cholangiopathy.